Role of reduction gastrectomy in patients with gastric cancer with a single non-curable factor: Supplementary analysis of REGATTA trial.

Masanori TerashimaKazumasa FujitaniHan-Kwang YangJunki MizusawaToshimasa TsujinakaKenichi NakamuraHiroshi KatayamaHyuk-Joon LeeJun Ho LeeJi-Yeong AnAkinori TakaganeYoung-Kyu ParkSeung Ho ChoiKyo Young SongSeiji ItoDo Joong ParkSung-Ho JinNarikazu BokuTakaki Yoshikawa Mitsuru Sasakonull null

Published in: Annals of gastroenterological surgery (2023)

Primary chemotherapy is a standard of care for advanced gastric cancer; however, the survival benefits from reduction by distal gastrectomy remained controversial.

Keyphrases

healthcare
palliative care
study protocol
clinical trial
neoadjuvant chemotherapy
minimally invasive
phase ii
randomized controlled trial
radiation therapy
double blind